John P. Lacyk

Array ( [id] => 3730206 [patent_doc_number] => 05670622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Conotoxin peptide PIIIA' [patent_app_type] => 1 [patent_app_number] => 8/599556 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9553 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670622.pdf [firstpage_image] =>[orig_patent_app_number] => 599556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662972 [patent_doc_number] => 05648469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Monoclonal antibodies reactive with transferrin receptor cytoplasmic domain' [patent_app_type] => 1 [patent_app_number] => 8/444418 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6070 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648469.pdf [firstpage_image] =>[orig_patent_app_number] => 444418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525036 [patent_doc_number] => 05541074 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Antibodies to dystrophin and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/342793 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 9996 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541074.pdf [firstpage_image] =>[orig_patent_app_number] => 342793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604472 [patent_doc_number] => 05578704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Antibody to osteoclast alphavbeta3 ntegrin' [patent_app_type] => 1 [patent_app_number] => 8/307844 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 8141 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578704.pdf [firstpage_image] =>[orig_patent_app_number] => 307844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642631 [patent_doc_number] => 05637300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception' [patent_app_type] => 1 [patent_app_number] => 8/285281 [patent_app_country] => US [patent_app_date] => 1994-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14006 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637300.pdf [firstpage_image] =>[orig_patent_app_number] => 285281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3794735 [patent_doc_number] => 05726293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Affinity purification methods involving imidazole elution' [patent_app_type] => 1 [patent_app_number] => 8/250317 [patent_app_country] => US [patent_app_date] => 1994-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 3645 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726293.pdf [firstpage_image] =>[orig_patent_app_number] => 250317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456889 [patent_doc_number] => 05472868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-05 [patent_title] => 'Stable rabbit-mouse fusion partner' [patent_app_type] => 1 [patent_app_number] => 8/230432 [patent_app_country] => US [patent_app_date] => 1994-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13387 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/472/05472868.pdf [firstpage_image] =>[orig_patent_app_number] => 230432 [rel_patent_id] =>[rel_patent_doc_number] =>)